Suppr超能文献

在美国新闻与世界报道评选出的顶尖心脏医院中,心力衰竭患者的死亡率和再入院率。

Mortality and readmission for patients with heart failure among U.S. News & World Report's top heart hospitals.

作者信息

Mulvey Gregory K, Wang Yun, Lin Zhenqiu, Wang Oliver J, Chen Jersey, Keenan Patricia S, Drye Elizabeth E, Rathore Saif S, Normand Sharon-Lise T, Krumholz Harlan M

机构信息

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.

出版信息

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):558-65. doi: 10.1161/CIRCOUTCOMES.108.826784. Epub 2009 Sep 1.

Abstract

BACKGROUND

The rankings of "America's Best Hospitals" by U.S. News & World Report are influential, but the performance of ranked hospitals in caring for patients with routine cardiac conditions such as heart failure is not known.

METHODS AND RESULTS

Using hierarchical regression models based on medical administrative data from the period July 1, 2005, to June 30, 2006, we calculated risk-standardized mortality rates and risk-standardized readmission rates for ranked and nonranked hospitals in the treatment of heart failure. The mortality analysis examined 14 813 patients in 50 ranked hospitals and 409 806 patients in 4761 nonranked hospitals. The readmission analysis included 16 641 patients in 50 ranked hospitals and 458 473 patients in 4627 nonranked hospitals. Mean 30-day risk-standardized mortality rates were lower in ranked versus nonranked hospitals (10.1% versus 11.2%, P<0.01), whereas mean 30-day risk-standardized readmission rates were no different between ranked and nonranked hospitals (23.6% versus 23.8%, P=0.40). The 30-day risk-standardized mortality rates varied widely for both ranked and nonranked hospitals, ranging from 7.9% to 12.4% for ranked hospitals and from 7.1% to 17.5% for nonranked hospitals. The 30-day risk-standardized readmission rates also spanned a large range, from 18.7% to 29.3% for ranked hospitals and from 19.2% to 29.8% for nonranked hospitals.

CONCLUSIONS

Hospitals ranked by U.S. News & World Report as "America's Best Hospitals" in "Heart & Heart Surgery" are more likely than nonranked hospitals to have a significantly lower than expected 30-day mortality rate, but there was much overlap in performance. For readmission, the rates were similar in ranked and nonranked hospitals.

摘要

背景

美国《新闻与世界报道》发布的“美国最佳医院”排名颇具影响力,但这些排名靠前的医院在护理心力衰竭等常规心脏疾病患者方面的表现尚不清楚。

方法与结果

利用2005年7月1日至2006年6月30日期间的医疗管理数据建立分层回归模型,我们计算了排名医院和未排名医院在治疗心力衰竭方面的风险标准化死亡率和风险标准化再入院率。死亡率分析纳入了50家排名医院的14813例患者和4761家未排名医院的409806例患者。再入院分析包括50家排名医院的16641例患者和4627家未排名医院的458473例患者。排名医院的30天风险标准化死亡率低于未排名医院(分别为10.1%和11.2%,P<0.01),而排名医院和未排名医院的30天风险标准化再入院率无差异(分别为23.6%和23.8%,P=0.40)。排名医院和未排名医院的30天风险标准化死亡率差异很大,排名医院为7.9%至12.4%,未排名医院为7.1%至17.5%。30天风险标准化再入院率范围也很广,排名医院为18.7%至29.3%,未排名医院为19.2%至29.8%。

结论

被美国《新闻与世界报道》评为“心脏与心脏外科”领域“美国最佳医院”的医院比未排名医院更有可能显著低于预期的30天死亡率,但在表现上有很大重叠。对于再入院率,排名医院和未排名医院相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验